These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 4657117)
41. Quinolones: which generation for which microbe? Lee MK; Kanatani MS West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165 [No Abstract] [Full Text] [Related]
42. Antimicrobial susceptibility of microorganisms recovered from intraabdominal infections at Belo Horizonte, Brazil. dos Santos SG; de Carvalho MA; Serufo JC; Pinto-Silva RA; Albuquerque W; Rosa RV; Pires Ade F; Hahn RC; Hamdan JS; Nicoli JR; Farias Lde M Am J Infect Control; 2004 Nov; 32(7):414-6. PubMed ID: 15525917 [TBL] [Abstract][Full Text] [Related]
43. [Octenidinedihydrochloride--a new antiseptic agent]. Braunwarth H Krankenpfl J; 2000; 38(3):63. PubMed ID: 10948897 [No Abstract] [Full Text] [Related]
44. Antimicrobials: an endangered species? Gould IM Int J Antimicrob Agents; 2007 Nov; 30(5):383-4. PubMed ID: 17825532 [No Abstract] [Full Text] [Related]
45. The new quinolones. Wise R Br J Hosp Med; 1986 Feb; 35(2):77. PubMed ID: 3730672 [No Abstract] [Full Text] [Related]
46. The withdrawal of antimicrobial treatment as a mechanism for defeating resistant microorganisms. Stokes DJ; Kelly AF; Gould SW; Cassar CA; Fielder MD FEMS Immunol Med Microbiol; 2008 Aug; 53(3):300-5. PubMed ID: 18554301 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic strategies involving antimicrobial treatment of large animals with peritonitis. Kunesh JP J Am Vet Med Assoc; 1984 Nov; 185(10):1222-5. PubMed ID: 6392261 [No Abstract] [Full Text] [Related]
49. Prospects and challenges in anti-infective research and development: new drugs and approaches. Labischinski H; Ruebsamen-Waigmann H Curr Opin Pharmacol; 2008 Oct; 8(5):519-21. PubMed ID: 18848903 [No Abstract] [Full Text] [Related]
50. [Current problems of antibacterial therapy]. Ludwig E Orv Hetil; 1998 Sep; 139(37):2179-84. PubMed ID: 9769686 [TBL] [Abstract][Full Text] [Related]
51. [Antimicrobial action of sorbic acid. VII. The antimicrobial action of compounds of sorbic acid and amino acids]. Rehm HJ; Lück E Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1967; 121(6):599-610. PubMed ID: 5633284 [No Abstract] [Full Text] [Related]
52. SPLUNC1 Loses Its Antimicrobial Activity in Acidic Cystic Fibrosis Airway Secretions. Ahmad S; Gilmore RC; Alexis NE; Tarran R Am J Respir Crit Care Med; 2019 Sep; 200(5):633-636. PubMed ID: 31013116 [No Abstract] [Full Text] [Related]
53. Therapeutic strategies involving antimicrobial treatment of ophthalmic disease in small animals. Peiffer RL; Cook CS; Möller I J Am Vet Med Assoc; 1984 Nov; 185(10):1172-5. PubMed ID: 6392250 [No Abstract] [Full Text] [Related]
54. [Use of antibacterial preparations in general practice. I. Distribution by diagnostic group]. Mabeck CE Ugeskr Laeger; 1981 Mar; 143(14):863-7. PubMed ID: 7292658 [No Abstract] [Full Text] [Related]
55. Therapeutic failures with antimicrobial drug treatment. Roberts MC J Am Vet Med Assoc; 1984 Nov; 185(10):1150-4. PubMed ID: 6439710 [No Abstract] [Full Text] [Related]
56. [Observations on the classification of antiviral, antimicrobial and antiparasitic agents according to their administration form and method of action]. Weuffen W Arch Exp Veterinarmed; 1967; 21(1):195-205. PubMed ID: 5604224 [No Abstract] [Full Text] [Related]